The pharmaceutical industry is expected to grow rapidly due to rising global medical needs, an aging population, the prevalence of chronic diseases, innovative treatments, personalized medicine, and expanding healthcare access in emerging markets.
Given the industry’s growth prospects, investors could consider buying fundamentally sound pharma stocks Spero Therapeutics, Inc. (SPRO), Astellas Pharma Inc. (ALPMY) and Supernus Pharmaceuticals, Inc. (SUPN) for solid returns.
